Teachers Retirement System of The State of Kentucky Trims Stake in HealthEquity, Inc. (NASDAQ:HQY)

Teachers Retirement System of The State of Kentucky reduced its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 2.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 51,281 shares of the company’s stock after selling 1,400 shares during the period. Teachers Retirement System of The State of Kentucky owned about 0.06% of HealthEquity worth $3,400,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in HQY. Cape Investment Advisory Inc. bought a new position in shares of HealthEquity in the fourth quarter worth approximately $27,000. McGlone Suttner Wealth Management Inc. bought a new position in shares of HealthEquity during the fourth quarter worth $29,000. DekaBank Deutsche Girozentrale bought a new position in shares of HealthEquity during the third quarter worth $41,000. Operose Advisors LLC bought a new position in shares of HealthEquity during the third quarter worth $44,000. Finally, Parallel Advisors LLC boosted its position in shares of HealthEquity by 255.5% during the fourth quarter. Parallel Advisors LLC now owns 679 shares of the company’s stock worth $45,000 after acquiring an additional 488 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Jon Kessler sold 33,765 shares of HealthEquity stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the completion of the sale, the chief executive officer now owns 126,635 shares in the company, valued at approximately $10,106,739.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CEO Jon Kessler sold 33,765 shares of HealthEquity stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the completion of the sale, the chief executive officer now owns 126,635 shares in the company, valued at approximately $10,106,739.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Vice Chairman Stephen Neeleman sold 400 shares of HealthEquity stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $85.00, for a total transaction of $34,000.00. Following the sale, the insider now owns 90,515 shares of the company’s stock, valued at approximately $7,693,775. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 68,745 shares of company stock valued at $5,482,530. 2.20% of the stock is currently owned by company insiders.

HealthEquity Trading Up 0.4 %

Shares of HQY opened at $84.74 on Wednesday. HealthEquity, Inc. has a twelve month low of $59.02 and a twelve month high of $87.72. The company has a market cap of $7.37 billion, a P/E ratio of 92.11, a P/E/G ratio of 1.38 and a beta of 0.55. The company has a current ratio of 4.39, a quick ratio of 4.39 and a debt-to-equity ratio of 0.44. The company’s fifty day simple moving average is $80.49 and its 200-day simple moving average is $77.34.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.08. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%. The business had revenue of $262.39 million for the quarter, compared to the consensus estimate of $258.56 million. As a group, analysts expect that HealthEquity, Inc. will post 2.13 EPS for the current year.

Wall Street Analysts Forecast Growth

HQY has been the subject of a number of research reports. Robert W. Baird upped their target price on shares of HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. Raymond James upped their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th. Bank of America upped their target price on shares of HealthEquity from $97.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday, June 4th. JMP Securities increased their price objective on shares of HealthEquity from $101.00 to $105.00 and gave the company a “market outperform” rating in a research report on Tuesday, June 4th. Finally, JPMorgan Chase & Co. increased their price objective on shares of HealthEquity from $86.00 to $108.00 and gave the company an “overweight” rating in a research report on Tuesday, April 2nd. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $101.42.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.